US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
Release time：2024-05-21 21:47:01 Source：International Identities news portal
WASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting industry practices that drive up pharmaceutical prices.
The Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions. The letters allege that certain patents filed by Novo Nordisk, GlaxoSmithKline, AstraZeneca and seven other companies are inaccurate or misleading.
Brand-name drugmakers use patents to protect their medicines and stave off cheaper, generic medicines. Most blockbuster drugs are protected by dozens of patents covering various ingredients, manufacturing processes and intellectual property. Generic drugmakers can only launch their own cheaper versions if the patents have expired or are successfully challenged in court.
- Previous：Everybody may love Raymond, but Ray Romano loves Peter Boyle
- Next：Investigators return to Long Island home of Gilgo Beach serial killing suspect
Related articles
- Israeli army says it kills over 130 militants in E. Rafah
- Australian town of Marble Bar clocks 26 consecutive days over 43 degrees Celsius
- Kenneth Eugene Smith: Alabama carries out first US nitrogen gas execution
- Waitangi 2024: Thousands stand in unity to challenge government on Treaty principles
- Ben Whishaw lights up the Croisette as he joins his co
- 'Unusually cool March': Cold but clear weather for Easter weekend
- Grammys 2024: Photos from the 66th annual awards
- Singapore minister Iswaran charged in rare corruption case
- Tourism boosts China's social, economic development
- Judges sceptical of Trump's immunity claim in election subversion case
- Joe Rogan's 'brain
- Christopher Luxon, Anthony Albanese to discuss defence and security at first official meeting
- Severe heatwave in eastern Australia to bring hottest weather in four years to NSW
- Japan launching new visa for digital nomads but will it be enough to solve its economic woes?
- 'The Apprentice,' about a young Donald Trump, premieres in Cannes
- Foreign Affairs Minister Winston Peters to resume 'Pacific reset' plan again
- Israel presses on with Gaza offensive approaching 100 days of war
- TikTok users losing access to Taylor Swift, Billie Eilish songs
- Company wins court ruling to continue development of Michigan factory serving EV industry
- Hong Kong denies entry to campaigner en route to Jimmy Lai trial — Radio Free Asia
Random recommendation